L3VLUP
ProSign in

LNTH · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

LNTHLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • LNTH
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterLNTHLLY
Q3 20201 holders, $34m33 holders, $14.1bn
Q4 20201 holders, $36m29 holders, $17.3bn
Q1 20212 holders, $71m24 holders, $23.0bn
Q2 20213 holders, $71m24 holders, $27.8bn
Q3 20212 holders, $57m31 holders, $29.9bn
Q4 20212 holders, $64m31 holders, $34.7bn
Q1 20228 holders, $299m24 holders, $35.3bn
Q2 20229 holders, $313m33 holders, $42.7bn
Q3 20229 holders, $357m31 holders, $43.4bn
Q4 202212 holders, $312m31 holders, $46.6bn
Q1 202316 holders, $723m33 holders, $44.3bn
Q2 202318 holders, $897m37 holders, $59.6bn
Q3 20239 holders, $628m44 holders, $67.6bn
Q4 20238 holders, $470m45 holders, $73.6bn
Q1 20249 holders, $431m41 holders, $95.3bn
Q2 20248 holders, $577m43 holders, $110bn
Q3 20247 holders, $830m45 holders, $107bn
Q4 20247 holders, $1.1bn46 holders, $93.9bn
Q1 20255 holders, $1.3bn42 holders, $98.4bn
Q2 20259 holders, $1.4bn43 holders, $93.2bn
Q3 20258 holders, $572m39 holders, $86.7bn
Q4 20256 holders, $862m41 holders, $123bn
Q1 20266 holders, $963m39 holders, $106bn
Q2 202610 holders, $1.6bn44 holders, $132bn
LNTH

Lantheus HLDGS Inc

Holders
9
Reported value
$1.4bn
Buyers
7
Sellers
1

Breadth +6 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUP
LLY

Eli Lilly & Co

Holders
43
Reported value
$93.2bn
Buyers
25
Sellers
22

Breadth +3 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 46 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only LNTH (3)

Bridgewater Associates LP, Farallon Capital Management LLC, Winton Group Ltd

Only LLY (37)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Marshall Wace LLP, Maverick Capital Ltd, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, and 12 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →